Effects of Kefir Consumption on Health Outcomes: Gastrointestinal System, Immunity, Biochemical Parameters, Body Composition, Sleep Quality and Mental Well Being in Healthy Adults
Launched by MEDIPOL UNIVERSITY · Sep 23, 2024
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
In order to evaluate the general characteristics, history of diseases and nutritional behaviors, a face-to-face questionnaire was conducted on all participants by the researchers. The questionnaire form contained information about the demographic information (age, gender, educational status, marital status, etc.), history of diseases (diagnosed diseases, drugs used etc.), basic nutritional habits (number of major meals/snacks consumed in a day, water consumption, etc.) and anthropometric measurements (body weight, height, body mass index, waist circumference, neck circumference). In the int...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteer to consume 250 mL of plain lactose-free kefir once a day,
- • Being healthy
- • Being 18-35 years of age.
- Exclusion Criteria:
- • Follow a special diet for health reasons,
- • Have an allergy to any food, have hepatic, renal and biliary diseases, have immunodeficiency, autoimmune and chronic gastrointestinal diseases, have a history of cancer, diabetes or cardiovascular diseases,
- • Being pregnant/breastfeeding,
- • Using vitamin-mineral and probiotic supplements,
- • Using antibiotics in last one month and throughout the study period,
- • Consuming probiotic foods or kefir on a regular basis,
- • Smoking
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Beykoz, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported